Skip to content
AwardedCzechiaGoodsCZK 272,150,000

Léčivé přípravky II [2026–2029]

Published
Published 29 April 2026
Deadline
Closed 1 June 2026

Overview

Masarykův onkologický ústav awarded a framework agreement for the supply of medicinal products from 2026 to 2029, split into four lots according to specification. Bristol-Myers Squibb spol. s r.o. and PROMEDICA PRAHA GROUP, a.s. won the contract on 10 June 2026 for 166.86 million CZK.

Key details

Country
Czechia
Status
Awarded
Category
Goods
Estimated value
CZK 272,150,000
Procedure
Open
Published
29 April 2026
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
CZK 166,860,629
Award date
10 June 2026
Contract period
1 July 2026 → 30 June 2029
Winners
  • Bristol-Myers Squibb spol. s r.o.
  • PROMEDICA PRAHA GROUP, a.s.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    10 July 2026

  2. Contract Notice

    29 April 2026

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Léčivé přípravky II [2026–2029] — won by Bristol-Myers Squibb spol. s r.o. +1 — Skim